EXTON, Pa. (AP) — EXTON, Pa. (AP) — West Pharmaceutical Services Inc. (WST) on Thursday reported third-quarter earnings of $136 million.

On a per-share basis, the Exton, Pennsylvania-based company said it had net income of $1.85.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $1.51 per share.

The medical device company posted revenue of $746.9 million in the period, also exceeding Street forecasts. Four analysts surveyed by Zacks expected $710.9 million.

West Pharmaceutical expects full-year earnings in the range of $6.55 to $6.75 per share, with revenue in the range of $2.88 billion to $2.91 billion.

_____

This story was generated by Automated Insights (https://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on WST at https://www.zacks.com/ap/WST